The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
Flamboyant keeper-batter Ishan Kishan walked into the middle and he looked in the mood as he played some impressive shots, including pulling O'Neill for a six.
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
Going into the penultimate game of the rubber, the pressing question is whether to tweak their conservative approach and bolster the spin department by playing left-arm wrist spinner Kuldeep Yadav at the cost of a spin all-rounder.
Two fast-bowling all-rounders look to be in a battle for one spot, while a decision between Prasidh Krishna and left-armer Arshdeep Singh could be condition-dependent.
India's batting faltered under pressure as they suffered a 22-run defeat in the third Test against England, at Lord's.
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.
Prema Katha Chitram 2 releases on March 21.
Hardcore Maoist Sriramula Srinivas alias Sudarshan, wanted in connection with several cases including the killing of former Andhra Home Minister A Madhava Reddy and carrying a reward of Rs 20 lakh on him, was arrested in Khammam district, police said on Sunday.
He steered the team away from trouble and kept grinding. His innings of 80 consisted of 6 fours and 2 maximums.
Jurel and Nitish Kumar Reddy then safely saw off the bowling to stay 73 for 5 till close of play, taking a 11-run lead.
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.
The Supreme Court asked the Chhattisgarh government some searching questions on disbanding the Salwa Judum, the anti-Naxal vigilante group accused of human rights violation in Maoist-hit tribal districts of the state, on Wednesday.
An excerpt from the order of the Supreme Court in the writ petition (civil) no 250 of 2007, Nandini Sundar and others versus State of Chattisgarh, in the court of Justice B Sudarshan Reddy
Take the case of Sudarshan Reddy, irrigation minister in the Andhra Pradesh government. He hails from the Bodan constituency in Nizamabad district and was supposed to return to his home constituency on Saturday. However, he advised against it due to the protests outside his house.
A Bench of Justices B Sudarshan Reddy and S S Nijjar dismissed the appeal filed by Natwar Singh and his son Jagat Singh for supply of certain documents and directed the authorities to expedite the inquiry, initiated in 2006 but delayed due to dilatory tactis of the father-son duo.
The Supreme Court on Monday stayed the death sentence of the three accused in connection with the Akshardham temple attack case of September 24, 2002 in which 34 persons, including two National Security Guard commandos were killed.
The Supreme Court on Wednesday directed the Centre to ensure that all schools and hostels of educational institutions occupied by the Army and paramilitary forces are vacated within two months. An order to this effect was passed by a bench comprising Justice B Sudarshan Reddy and Justice S S Nijjar during the hearing of the issue relating to the trafficking of 76 children from Manipur and Assam to Tamil Nadu.
The Mumbai SEZ Ltd, promoted jointly by industrialist Mukesh Ambani and his confidant Anand Jain, runs the risk of being scrapped after the Supreme Court on Friday refused to stay the land acquisition process that otherwise has to conclude by June 8.
The new Congress government had provided five per cent reservation in jobs to Muslims.
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
Former judges of the Supreme Court and high courts and some senior advocates have written a letter to the Chief Justice of India NV Ramana requesting the top court to take suo motu cognisance of the detention of protestors and demolition of their houses by the Uttar Pradesh authorities following protests against objectionable remarks made by BJP spokespersons.
Senior leaders Damodar Raja Narsimha, Ponnala Lakshmaiah and Kunduru Jana Reddy figure in the list of 111 Congress candidates for assembly elections in Telangana released by the party on Monday night, ending two days of suspense.
Leaders of the opposition parties had on Friday met Naidu and handed over the notice of impeachment against the chief justice of India bearing signatures of 64 MPs and seven former members, who recently retired.
If the Congress is contesting fewer seats than ever before, the BJP is set to contest its highest-ever number of Lok Sabha seats.
A depleted Gujarat Titans bowling attack will have to raise its game by quite a few notches to stop a marauding Sunrisers Hyderabad, fresh from its record total against Mumbai Indians, in the upcoming afternoon IPL match in Ahmedabad on Sunday.
Srinivas Bhogle and Purnendu Maji present Rediff.com's Most Valuable Player Index of IPL 2024 after Game 62.
Srinivas Bhogle and Purnendu Maji present Rediff.com's Most Valuable performances of IPL 2024
Srinivas Bhogle and Purnendu Maji present Rediff.com's Most Valuable Player Index of IPL 2024 after Game 37.
Realty major DLF's chairman Rajiv Singh remains the wealthiest Indian real estate entrepreneur with a wealth of Rs 59,030 crore, according to GROHE-HURUN India. With a wealth of Rs 42,270 crore, Mangal Prabhat Lodha and his family of Mumbai-based Macrotech Developers (Lodha Group) is at the second position. Arjun Menda & family of Bengaluru-based RMZ Corp debuted at the third position on the list, with a wealth of Rs 37,000 crore.
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.
Industry leaders, including Mahindra Group chairman Anand Mahindra, RPG Enterprises chairman Harsh Goenka and Biocon Ltd chairperson Kiran Mazumdar-Shaw on Monday came out in support of the Agnipath scheme, saying it has large potential for employment of youth in the corporate sector. Mahindra also expressed dismay over the violence against the scheme while asserting that the farm equipment to aerospace conglomerate welcomes the opportunity to recruit trained, capable and young people under the programme. The Agnipath scheme, announced on June 14, provides for the recruitment of youths between the age bracket of 17-and-half years to 21 for only four years with a provision to retain 25 per cent of them for 15 more years.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.
The rejection of the notice comes a day after Naidu held the consultations with such experts to determine the maintainability of the motion.
Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family.
Indian auto and pharma industries import several critical components and raw materials from China.
As the dust finally settles on the outcome of the Lok Sabha elections 2019 and Bharatiya Janata Party along with its NDA allies emerges as the clear winner, here is a list of who won in each of the 7 phases of elections.
In an online chat with readers, overseas consultant NNS Chandra offers career advice.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances